Marquette Asset Management’s Standard BioTools LAB Stock Holding History

Marquette Asset Management’s Portfolio LAB Stock Details LAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-325,345	Closed	-$268K	–	854
2026 Q2	$268K	Buy	+325,345	New	+$307K	0.03%	82

Other funds holding LAB

DIM

DLK Investment Management Solana Beach, California $275M AUM 10.69% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Marquette Asset Management's LAB Position: Q3 2026 in Review

Marquette Asset Management sold out of Standard BioTools (LAB) in Q3 2026, closing a stake of 325,345 shares — an estimated $268K sold.

Marquette Asset Management first reported a position in LAB in Q2 2026 and held it in 1 quarter. The position peaked at $268K in Q2 2026. 3 funds tracked by Wall St. Rank hold LAB as of Q3 2026.

Marquette Asset Management reported no remaining Standard BioTools position as of Q3 2026 after selling out during the quarter.
Marquette Asset Management sold 325,345 Standard BioTools shares in Q3 2026, an estimated $268K.
Marquette Asset Management first reported a position in Standard BioTools in Q2 2026 and held it in 1 quarter.
Marquette Asset Management's Standard BioTools position peaked at $268K in Q2 2026.
3 funds tracked by Wall St. Rank held Standard BioTools as of Q3 2026.

Based on Marquette Asset Management's 13F filing for Q3 2026, filed 9 Oct 2026.